Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ccd.29675 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Thrombocytopenia after transcatheter aortic valve implantation.
Rev Esp Cardiol (Engl Ed)
September 2024
Instituto Cardiovascular, Hospital Clínico San Carlos, IdISSC, Madrid, Spain. Electronic address:
Introduction And Objectives: Thrombocytopenia frequently occurs after transcatheter aortic valve implantation (TAVI) but its impact is poorly understood. We aimed to analyze the incidence, clinical impact, and predictors of acquired thrombocytopenia after TAVI.
Methods: This retrospective multicenter registry included 3913 patients undergoing TAVI with a baseline platelet count of ≥ 100 *10/L.
Coagulation, fibrinolysis and platelet drop in patients undergoing transfemoral transcatheter aortic valve implantation.
Catheter Cardiovasc Interv
November 2024
Department of Cardiology, Teikyo University School of Medicine, Tokyo, Japan.
Background: Transcatheter aortic valve implantation (TAVI) leads to transient platelet activation and hypercoagulation status, resulting in thrombocytopenia.
Aims: This study investigated the associations of coagulation/fibrinolysis status after transfemoral TAVI with valve type, post-TAVI thrombocytopenia, and complication of TAVI.
Methods: Thrombin-antithrombin complex (TAT) and fibrin/fibrinogen degradation product (FDP) levels were measured before and 1 h, 1 day, and 2 days after TAVI.
Platelet Reduction after Transcatheter Aortic Valve Implantation: Results from the PORTRAIT Study.
J Clin Med
March 2024
Department of Cardio-Thoracic Surgery, Heart & Vascular Centre, Maastricht University Medical Centre (MUMC), Cardiovascular Research Institute Maastricht (CARIM), 6229 Maastricht, The Netherlands.
An unexplained condition that follows transcatheter aortic valve implantation (TAVI) is platelet count reduction (PR). According to published research, patients with balloon-expandable valves (BEVs) had a greater PR than those with self-expandable valves (SEVs). The purpose of this study was to investigate the incidence and clinical effects of PR following TAVI.
View Article and Find Full Text PDF[Research progress on pathogenesis of thrombocytopenia associated with TAVI].
Zhonghua Xin Xue Guan Bing Za Zhi
February 2024
Department of Cardiovascular Medicine, People's Hospital of Jiangxi Province, Nanchang 333006, China.
Acquired Thrombocytopenia in Contemporary Transcatheter Aortic Valve Prosthesis.
Thorac Cardiovasc Surg
December 2023
Department of Cardiac Surgery, Heart Centre Dresden, University Hospital of the University of Technology Dresden, Dresden, Sachsen, Germany.
Background: Postprocedural thrombocytopenia is a known phenomenon following transcatheter aortic valve implantation (TAVI). The aim of this study is to evaluate whether postinterventional platelet kinetics differ when comparing the current generation of balloon-expandable valve (BEV) and self-expanding valve (SEV) prostheses.
Methods: We performed a retrospective analysis of patients undergoing TAVI at our facility between 2017 and 2019.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!